Results 211 to 220 of about 23,377 (288)
Setmelanotide in Bardet‐Biedl Syndrome: A Case Report
ABSTRACT Setmelanotide is a melanocortin‐4‐receptor agonist used for the treatment of hyperphagia in the genetic obesity syndrome Bardet‐Biedl. Presented is a case of diffuse hyperpigmentation in a patient treated with setmelanotide, which represents the most common side effect of this medication.
Shelby Smith +2 more
wiley +1 more source
Sustained Remission of Pediatric Bowel‐Associated Dermatosis‐Arthritis Syndrome With Risankizumab
ABSTRACT Bowel‐associated dermatosis‐arthritis syndrome (BADAS) is a rare neutrophilic dermatosis characterized by recurrent fever, arthralgias, and skin eruptions, most commonly occurring in patients with inflammatory bowel disease. We report the case of a 17‐year‐old female with Crohn's disease who developed BADAS and achieved complete and durable ...
Kylie E. Peake +4 more
wiley +1 more source
Apremilast combined with low-dose corticosteroids for lichenoid drug eruption following programmed cell death protein 1 inhibitor and lenvatinib therapy: A case report. [PDF]
Meng X, Li D, Zhou B, Liu J, Xu Y.
europepmc +1 more source
Exercise‐Induced Vasculitis in a 12‐Year‐Old Child: A Case Report
ABSTRACT Exercise‐induced vasculitis (EIV), colloquially known as “Disney rash,” is a benign, self‐limited leukocytoclastic vasculitis of the lower extremities triggered by prolonged exertion in warm weather, well‐recognized in adults but underappreciated in children.
Beverly X. Yu +3 more
wiley +1 more source
The Use of Etanercept in the Palliative Treatment of a Patient With Generalised Bullous Fixed Drug Eruption. [PDF]
Pawlik O, Cowan T, Miller A.
europepmc +1 more source
ABSTRACT Psoriasiform eruptions have been described in patients treated with dupilumab. This case report describes an adolescent with severe atopic dermatitis who developed a widespread psoriasiform dermatitis 8 months after starting dupilumab. His therapy was switched to abrocitinib resulting in near‐complete resolution of the psoriatic lesions with ...
Grigorios Theodosiou, Åke Svensson
wiley +1 more source
Cross-Reactivity: a Case of Paracetamol-Induced Generalized Bullous Fixed Drug Eruption Followed by Dipyrone-Induced Fixed Drug Eruption. [PDF]
Wang Y, Xue H, Dai H, Yang L.
europepmc +1 more source
In this model, ROS generated by UVB result in PAFR agonists acting upon the PAFR resulting in MVP generation release via the enzyme aSMase. In photosensitivity, there are increased ROS, resulting in augmented PAF agonists and increased MVP release. This process can be blocked by aSMase inhibitors.
Risha Annamraju +13 more
wiley +1 more source
Delayed lichenoid drug eruption associated with apremilast. [PDF]
Hinderks-Davis B, Hintz M, Green AL.
europepmc +1 more source

